Bookmark and Share

(SIMH) Caregiver TouchFree Infrared Clinical Thermometer Awarded

Annual Event Identifies Healthcare Products That Improve Patient Outcomes and Enhance Patient and Provider Safety

MIAMI, Oct. 24, 2014  — Thermomedics, Inc, a division of Sanomedics (OTCQB:SIMH) announced that its Caregiver® TouchFree™ Clinical Thermometer was awarded the coveted Innovative Technology designation by Novation at its Innovative Technology Expo on Sept. 10, 2014, at the Irving Convention Center, Irving, Texas.

The Caregiver does not require probe-covers, since it does not contact the patient, making it ideal for reducing risk of transmission of infectious disease. It takes temperature in 1-2 seconds and is easy-to-use with minimal inservice. The lack of probe covers also contributes to reduction of plastic waste and reduces costs for storage, as well.

The Caregiver was awarded the Innovative Technology designation following a review by more than 200 attendees from hospitals around the United States who serve on a Novation council or task force and participated in the Expo. These key opinion leaders indicated the Thermomedics Caregiver device offered incremental benefit over other products available on the market.

Olya Carter, RN and Senior Clinical Manager at Novation said, “Hospital participants strongly supported the Thermomedics Caregiver TouchFree Thermometer. They identified the Caregiver as the way to provide superior patient care by allowing them to efficiently assess their patients in the safest possible way.”

Keith Houlihan, Company President, noted that “this medical instrument is a breakthrough in patient care and reduces costs, time and technique-dependence while upgrading standards of practice. Our TouchFree technology is the world leader in contagion risk avoidance.”

This new designation will also identify Thermomedics’ Caregiver® TouchFree™ Clinical Thermometer as an awarded Innovative Technology product within Novation’s online contract catalog, which is accessible by the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association, and Provista served by Novation. This heightened visibility will encourage further consideration by members accessing this agreement.

To learn more about Novation’s Innovative Technology program, visit

About Sanomedics International Holdings, Inc.

Sanomedics International Holdings, Inc. (OTCQB:SIMH) is a medical technology holding company that focuses on game changing products, services and ideas — a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

Sign up for Sanomedics email news alert system today at:

Follow us on Twitter @Sanomedics and tweet us!

About Novation, Winner of the Ethics Inside® Certification

Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children’s Hospital Association, an alliance of the nation’s leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 800 suppliers. Members of VHA, UHC, Children’s Hospital Association and Provista used Novation contracts to purchase approximately $49 billion in 2013. Novation has earned the coveted Ethics Inside® Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance. Novation was also named on Ethisphere’s World’s Most Ethical Companies list and is the only company in the health care industry to earn both distinctions for three consecutive years. To learn more about Novation, please visit and follow @NovationNews.

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company’s periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

CONTACT: Keith Houlihan
         Sanomedics International Holdings, Inc.
Friday, October 24th, 2014 Uncategorized